Bayesian Capital Management’s Solventum SOLV Stock Holding History
Bought
Maintained
Sold
Other funds holding SOLV
IFP
TFM
DSA
Bayesian Capital Management's SOLV Position: Q2 2026 in Review
Bayesian Capital Management opened a new position in Solventum (SOLV) in Q2 2026: 4,100 shares worth $316K. The stake represents 0.2% of the portfolio and ranks #144 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in SOLV as recently as Q2 2025.
Bayesian Capital Management first reported a position in SOLV in Q2 2025 and has held it in 2 quarters since. The position peaked at $362K in Q2 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.
- Bayesian Capital Management held 4,100 shares of Solventum worth $316K as of Q2 2026.
- Solventum was a new Bayesian Capital Management position in Q2 2026.
- Solventum made up 0.2% of Bayesian Capital Management's portfolio in Q2 2026, its #144 holding.
- Bayesian Capital Management first reported a position in Solventum in Q2 2025 and has held it in 2 quarters since.
- Bayesian Capital Management's Solventum position peaked at $362K in Q2 2025.
- 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.